Virtual Collaborations Push Pharma Forward During Pandemic

With regions of the world cycling through societal re-openings and shutdowns due to the ongoing coronavirus pandemic, pharma and life science companies are tasked with trying to find creative solutions that help keep production lines moving, as well as drive innovation forward. For instance, pharmaceutical manufacturers still need to meet critical project timelines so that patients receive the therapies they require. As such, many companies require varying levels of technical support to accomplish their goals—a scenario made much more difficult due to travel and in-person meeting restrictions. Thankfully, the resilient team at the M Lab™ Collaboration Centers from MilliporeSigma were able to work out virtual solutions to support their partner Vuab Pharma reach their manufacturing goals. Take a listen to this latest GENcast and see how the virtual world stepped up to help the pharma space. Hosted on Acast. See acast.com/privacy for more information.

Om Podcasten

Genetic Engineering & Biotechnology News (GEN) has retained its position as the premier biotech publication since its launch in 1981. GEN publishes a print edition monthly and has additional exclusive editorial content online, including news and analysis as well as webinars, videos, and polls. GEN's unique news and technology focus covers the entire bioproduct life cycle, including drug discovery, early-stage R&D, applied research (e.g., omics, biomarkers, and diagnostics), bioprocessing, and commercialization.GEN's print magazine, which also can easily be accessed online, includes feature articles on emerging technologies, product roundups, in-depth overviews from key scientific and bioindustry meetings, and industry-standard tutorials and technical articles on drug discovery, bioprocessing, and assay technologies. Hosted on Acast. See acast.com/privacy for more information.